Skip to main content

Table 4 Comparative performance of host gene methylation markers to discern CIN3 + in urine and cervicovaginal swab self-samples

From: The current state of DNA methylation biomarkers in self-collected liquid biopsies for the early detection of cervical cancer: a literature review

Marker

Sample type

n=

Population

AUC

Confidence interval (95%)

Study

GHSR

Urine

74

Referral

0.7

0.56–0.84

van den Helder, 2020

GHSR

Cervicovaginal swab

304

Screening

0.645

0.576–0.714

de Waard, 2023

GHSR

Urine

33

Referral

0.769

0.561–0.897

Van Keer, 2021

GHSR

Urine

245

Referral

0.79

0.72–0.84

van den Helder, 2022

ST6GALNAC5

Urine

33

Referral

0.628

0.465–0.725

Van Keer, 2021

ST6GALNAC5

Cervicovaginal swab

304

Screening

0.676

0.609–0.627

de Waard, 2023

SST

Urine

74

Referral

0.73

0.59–0.86

van den Helder, 2020

SST

Urine

33

Referral

0.634

0.473–0.809

Van Keer, 2021

SST

Cervicovaginal swab

304

Screening

0.7

0.637–0.764

de Waard, 2023

SST

Urine

245

Referral

0.72

0.65–0.79

van den Helder, 2022

ZIC1

Urine

74

Referral

0.62

0.47–0.77

van den Helder, 2020

ZIC1

Urine

33

Referral

0.558

0.400–0.742

Van Keer, 2021

ZIC1

Urine

245

Referral

0.72

0.66–0.78

van den Helder, 2022

ZIC1

Cervicovaginal swab

304

Screening

0.787

0.729–0.863

de Waard, 2023

LHX8

Urine

74

Referral

0.68

0.54–0.82

van den Helder, 2020

LHX8

Urine

33

Referral

0.682

0.465–0.842

Van Keer, 2021

LHX8

Urine

245

Referral

0.78

0.72–0.83

van den Helder, 2022

LHX8

Cervicovaginal swab

304

Screening

0.781

0.721–0.841

de Waard, 2023

ASCL1

Urine

74

Referral

0.79

0.67–0.91

van den Helder, 2020

ASCL1

Urine

33

Referral

0.566

0.473–0.849

Van Keer, 2021

ASCL1

Cervicovaginal swab

304

Screening

0.806

0.749–0.863

de Waard, 2023

ASCL1

Urine

245

Referral

0.83

0.77–0.88

van den Helder, 2022